Carla M. Van Herpen
Nijmegen, GE 6525GA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 205 publications
Evolving Concepts in Salivary Duct Carcinoma: A Narrative Review.
Journal: Oncology and therapy
Published: April 13, 2026
Real-world effectiveness of molecular-matched therapies in salivary gland cancer.
Journal: ESMO open
Published: January 08, 2026
Cytotoxic CD4+ T cells in cancer: an emerging target for next-generation anticancer immunotherapy?
Journal: Journal for immunotherapy of cancer
Published: December 05, 2025
[89Zr]Zr-DFO-avelumab accumulation in resectable non-small cell lung carcinoma indicates a suppressive tumor microenvironment amendable to neoadjuvant avelumab treatment.
Journal: Immunotherapy advances
Published: May 08, 2025
Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity.
Journal: Journal for immunotherapy of cancer
Published: April 18, 2025
The effect of androgen blockade on [68Ga]Ga-PSMA-11 and [18F]FDG PET uptake in patients with recurrent or metastatic salivary duct carcinoma: a prospective imaging study.
Journal: EJNMMI research
Published: February 25, 2025
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 18, 2025
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 28, 2025
Exploring the relation between TGF-β pathway activity and response to checkpoint inhibition in patients with metastatic melanoma.
Journal: Clinical and experimental immunology
Published: June 25, 2024
Last Updated: 09/26/2026